Sixth CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

Conference cochairs

Özlem Türeci, BioNTech SE, Mainz, Germany
E. John Wherry, University of Pennsylvania, Philadelphia, Pennsylvania
Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, New York

Scientific Planning Committee

James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, Texas
Mario Colombo, Italian National Cancer Institute, Milan, Italy
Lisa M. Coussens, Oregon Health and Sciences University, Portland, Oregon
Silvia C. Formenti, Weill Cornell Medical Center, New York, New York
Christoph Huber, Association for Cancer Immunotherapy, Mainz, Germany
Carl H. June, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France
Ellen Puré, University of Pennsylvania, Philadelphia, Pennsylvania
Jennifer Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas

The Cancer Research Institute (CRI), the European Network for Cancer Immunology (ENCI), and the American Association for Cancer Research (AACR) are proud to once again join forces to present the International Cancer Immunotherapy Conference. The program will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy. This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates. 

#cicon22

Continuing Medical Education Activity AMA PRA Category 1 Credits^TM available